TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Svea Vaccin AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
160,003
|
228,073
|
114,229 |
Financial expenses |
0
|
40
|
21 |
Earnings before taxes |
17,736
|
50,551
|
5,774 |
EBITDA |
17,058
|
50,819
|
6,214 |
Total assets |
35,247
|
64,738
|
31,934 |
Current assets |
32,132
|
62,034
|
28,890 |
Current liabilities |
19,640
|
24,211
|
27,291 |
Equity capital |
14,670
|
40,527
|
4,643 |
- share capital |
95
|
98
|
105 |
Employees (average) |
65
|
80
|
49 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
41.6%
|
62.6%
|
14.5% |
Turnover per employee |
2,462
|
2,851
|
2,331 |
Profit as a percentage of turnover |
11.1%
|
22.2%
|
5.1% |
Return on assets (ROA) |
50.3%
|
78.1%
|
18.1% |
Current ratio |
163.6%
|
256.2%
|
105.9% |
Return on equity (ROE) |
120.9%
|
124.7%
|
124.4% |
Change turnover |
-61,216
|
121,736
|
-21,919 |
Change turnover % |
-28%
|
114%
|
-16% |
Chg. No. of employees |
-15
|
31
|
2 |
Chg. No. of employees % |
-19%
|
63%
|
4% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.